首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1534246

全球靜脈 (IV) 設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Intravenous (IV) Equipment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球靜脈（IV）設備市場需求預計將從2023年的214.2億美元達到2032年近399.8億美元的市場規模，2024-2032年研究期間的複合年成長率為7.18%。

靜脈 (IV) 設備包括醫療保健環境中使用的一系列設備和配件，透過靜脈治療將液體、藥物和營養物質直接注射到患者的血液中。其中包括 IV 導管、輸液幫浦、IV 溶液袋、管道套件以及連接器和針頭等配件。靜脈注射設備對於提供精確劑量的藥物和液體、確保住院、手術、緊急治療和慢性病管理期間有效的患者護理至關重要。

市場動態

靜脈 (IV) 設備市場是由癌症、糖尿病和心血管疾病等需要靜脈治療的慢性疾病盛行率上升所推動的。輸液幫浦、導管和管道系統的技術創新提高了安全性、準確性和患者舒適度，推動了市場擴張。此外，全球醫療保健支出的增加和發展中地區醫療保健設施的擴大為市場滲透創造了機會。對家庭醫療保健解決方案和門診護理環境的需求也促進了攜帶式和方便用戶使用的靜脈輸液設備的採用，促進患者的活動並提高生活品質。

此外，促進病患安全和醫療保健品質標準的監管措施鼓勵採用具有無線連接、整合監測系統和自動劑量計算等功能的先進靜脈注射設備。醫療保健提供者和技術公司之間在產品開發和分銷方面的策略合作夥伴關係增強了市場競爭力並擴大了產品組合。此外，COVID-19 大流行凸顯了靜脈注射治療在重症患者管理中的重要性，推動了重症監護病房和急診對輸液幫浦、靜脈輸液和相關設備的即時需求。這種激增加速了對靜脈輸液設備製造和供應鏈彈性的投資，確保醫療危機期間的持續可用性。然而，定價壓力、報銷不確定性、感染控制和設備安全問題可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球靜脈 (IV) 設備市場的各個細分市場進行了包容性評估。靜脈 (IV) 設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

靜脈 (IV) 設備市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

靜脈導管
管理集
點滴幫浦
固定裝置
滴水室
旋塞閥和止回閥
無需連接器
其他

按最終用戶

醫院和診所
診斷中心
門診手術中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲靜脈 (IV) 設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。靜脈 (IV) 設備市場的主要參與者包括 B. Braun Melsungen AG、3M、Terumo Corporation、Abbott、Teleflex Incorporated、BD、Henry Schein Inc.、Smiths Medical、Baxter、Ascor SA、Moog Inc.、AngioDynamics。 Inc.、Fresenius SE & Co. KGaA、Animas LLC、Arcomed Ag、International Win Ltd。合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：靜脈 (IV) 設備公司的競爭格局

靜脈（IV）設備市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
B. Braun Melsungen AG

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Terumo Corporation

公司概況
公司收入
產品
最新動態

Abbott

公司概況
公司收入
產品
最新動態

Teleflex Incorporated

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Henry Schein Inc.

公司概況
公司收入
產品
最新動態

Smiths Medical

公司概況
公司收入
產品
最新動態

Baxter

公司概況
公司收入
產品
最新動態

Ascor SA

公司概況
公司收入
產品
最新動態

Moog Inc.

公司概況
公司收入
產品
最新動態

AngioDynamics.

公司概況
公司收入
產品
最新動態

ICU Medical Inc.

公司概況
公司收入
產品
最新動態

Fresenius SE & Co. KGaA

公司概況
公司收入
產品
最新動態

Animas LLC

公司概況
公司收入
產品
最新動態

Arcomed Ag

公司概況
公司收入
產品
最新動態

International Win Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115319

The global demand for Intravenous (IV) Equipment Market is presumed to reach the market size of nearly USD 39.98 Billion by 2032 from USD 21.42 Billion in 2023 with a CAGR of 7.18% under the study period 2024-2032.

Intravenous (IV) equipment encompasses a range of devices and accessories used in healthcare settings to administer fluids, medications, and nutrients directly into patients' bloodstreams via intravenous therapy. These include IV catheters, infusion pumps, IV solution bags, tubing sets, and accessories such as connectors and needles. IV equipment is crucial in delivering precise doses of medications and fluids, ensuring efficient patient care during hospitalization, surgery, emergency treatment, and chronic disease management.

MARKET DYNAMICS

The Intravenous (IV) Equipment market is driven by the rising prevalence of chronic diseases requiring intravenous therapy, such as cancer, diabetes, and cardiovascular disorders. Technological innovations in infusion pumps, catheters, and tubing systems enhance safety, accuracy, and patient comfort, driving market expansion. Moreover, rising healthcare expenditure globally and expanding healthcare facilities in developing regions create opportunities for market penetration. Demand for home healthcare solutions and ambulatory care settings also boosts the adoption of portable and user-friendly IV equipment, facilitating patient mobility and improving quality of life.

Furthermore, regulatory initiatives promoting patient safety and healthcare quality standards encourage the adoption of advanced IV equipment with features such as wireless connectivity, integrated monitoring systems, and automated dose calculations. Strategic partnerships between healthcare providers and technology firms for product development and distribution strengthen market competitiveness and expand product portfolios. Additionally, the COVID-19 pandemic has underscored the importance of IV therapy in managing critically ill patients, driving immediate demand for infusion pumps, IV fluids, and related equipment in intensive care units and emergency departments. This surge has accelerated investments in IV equipment manufacturing and supply chain resilience, ensuring continuous availability during healthcare crises. However, pricing pressures, reimbursement uncertainties, infection control, and device safety concerns may hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous (IV) Equipment. The growth and trends of Intravenous (IV) Equipment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous (IV) Equipment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

IV Catheters
Administration Sets
Infusion Pumps
Securement Devices
Drip Chambers
Stopcocks and Check Valves
Needless Connectors
Others

By End-User

Hospitals and clinics
Diagnostic Centers
Ambulatory Surgical Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous (IV) Equipment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous (IV) Equipment market include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein Inc., Smiths Medical, Baxter, Ascor S.A., Moog Inc., AngioDynamics., ICU Medical Inc., Fresenius SE & Co. KGaA, Animas LLC, Arcomed Ag, International Win Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INTRAVENOUS (IV) EQUIPMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-User
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. IV Catheters Historic and Forecast Sales By Regions
5.4. Administration Sets Historic and Forecast Sales By Regions
5.5. Infusion Pumps Historic and Forecast Sales By Regions
5.6. Securement Devices Historic and Forecast Sales By Regions
5.7. Drip Chambers Historic and Forecast Sales By Regions
5.8. Stopcocks and Check Valves Historic and Forecast Sales By Regions
5.9. Needless Connectors Historic and Forecast Sales By Regions
5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY END-USER

6.1. Overview By End-User
6.2. Historical and Forecast Data Analysis By End-User
6.3. Hospitals and clinics Historic and Forecast Sales By Regions
6.4. Diagnostic Centers Historic and Forecast Sales By Regions
6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS (IV) EQUIPMENT MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS (IV) EQUIPMENT COMPANIES

8.1. Intravenous (IV) Equipment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF INTRAVENOUS (IV) EQUIPMENT INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. B. Braun Melsungen AG
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. 3M
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Terumo Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Abbott
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Teleflex Incorporated
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. BD
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Henry Schein Inc.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Smiths Medical
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Baxter
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Ascor S.A.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Moog Inc.
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments
9.14. AngioDynamics.
- 9.14.1 Company Overview
- 9.14.2 Company Revenue
- 9.14.3 Products
- 9.14.4 Recent Developments
9.15. ICU Medical Inc.
- 9.15.1 Company Overview
- 9.15.2 Company Revenue
- 9.15.3 Products
- 9.15.4 Recent Developments
9.16. Fresenius SE & Co. KGaA
- 9.16.1 Company Overview
- 9.16.2 Company Revenue
- 9.16.3 Products
- 9.16.4 Recent Developments
9.17. Animas LLC
- 9.17.1 Company Overview
- 9.17.2 Company Revenue
- 9.17.3 Products
- 9.17.4 Recent Developments
9.18. Arcomed Ag
- 9.18.1 Company Overview
- 9.18.2 Company Revenue
- 9.18.3 Products
- 9.18.4 Recent Developments
9.19. International Win Ltd
- 9.19.1 Company Overview
- 9.19.2 Company Revenue
- 9.19.3 Products
- 9.19.4 Recent Developments